Human transporter database: comprehensive knowledge and discovery tools in the human transporter genes
- PMID: 24558441
- PMCID: PMC3928311
- DOI: 10.1371/journal.pone.0088883
Human transporter database: comprehensive knowledge and discovery tools in the human transporter genes
Erratum in
- PLoS One. 2014;9(5):e98396
Abstract
Transporters are essential in homeostatic exchange of endogenous and exogenous substances at the systematic, organic, cellular, and subcellular levels. Gene mutations of transporters are often related to pharmacogenetics traits. Recent developments in high throughput technologies on genomics, transcriptomics and proteomics allow in depth studies of transporter genes in normal cellular processes and diverse disease conditions. The flood of high throughput data have resulted in urgent need for an updated knowledgebase with curated, organized, and annotated human transporters in an easily accessible way. Using a pipeline with the combination of automated keywords query, sequence similarity search and manual curation on transporters, we collected 1,555 human non-redundant transporter genes to develop the Human Transporter Database (HTD) (http://htd.cbi.pku.edu.cn). Based on the extensive annotations, global properties of the transporter genes were illustrated, such as expression patterns and polymorphisms in relationships with their ligands. We noted that the human transporters were enriched in many fundamental biological processes such as oxidative phosphorylation and cardiac muscle contraction, and significantly associated with Mendelian and complex diseases such as epilepsy and sudden infant death syndrome. Overall, HTD provides a well-organized interface to facilitate research communities to search detailed molecular and genetic information of transporters for development of personalized medicine.
Conflict of interest statement
Figures
References
-
- Nelson DL, Lehninger AL, Cox MM (2008) Lehninger principles of biochemistry. New York: W.H. Freeman.
-
- Overington JP, Al-Lazikani B, Hopkins AL (2006) How many drug targets are there? Nat Rev Drug Discov 5: 993–996. - PubMed
-
- Rask-Andersen M, Almen MS, Schioth HB (2011) Trends in the exploitation of novel drug targets. Nat Rev Drug Discov 10: 579–590. - PubMed
-
- Ware JA (2006) Membrane transporters in drug discovery and development: A new mechanistic ADME era. Mol Pharm 3: 1–2. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
